COVALENT 112—A Clinical Trial Assessing BMF-219, an Oral Covalent Menin Inhibitor in Type 1 Diabetes

BMF-219 - Biomea Fusion

https://diabetesjournals.org/diabetes/article/73/Supplement_1/901-P/156533/901-P-COVALENT-112-A-Clinical-Trial-Assessing-BMF

HIEN T. TRAN; DANIEL KATSELNIK; DOUGLAS S. DENHAM; MICHELLE K. STEVENS-BROGAN; CARL W. DECKER; SANCHITA MOURYA; JUAN P. FRIAS; THOMAS BUTLER; CRISTINA B. GUZMAN

May 21, 2024